BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15181859)

  • 1. Risperidone long-acting injection: a brief overview.
    Lemon M
    S D J Med; 2004 May; 57(5):171-2. PubMed ID: 15181859
    [No Abstract]   [Full Text] [Related]  

  • 2. An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia.
    Dursun S
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):3-4. PubMed ID: 16144780
    [No Abstract]   [Full Text] [Related]  

  • 3. New for old? Risperidone long-acting injection in older patients.
    Hudson-Jessop P; Hughes B; Brinkley N
    Australas Psychiatry; 2007 Dec; 15(6):461-4. PubMed ID: 17999255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of long-acting risperidone.
    Parker G
    Psychiatr Serv; 2005 Jan; 56(1):105-6; author reply 106-7. PubMed ID: 15637203
    [No Abstract]   [Full Text] [Related]  

  • 5. [The first long-acting atypical antipsychotic: new milestone in the treatment of schizophrenia].
    Faludi G
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):22-7. PubMed ID: 16167464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical review of a long-acting, injectable formulation of risperidone.
    Knox ED; Stimmel GL
    Clin Ther; 2004 Dec; 26(12):1994-2002. PubMed ID: 15823763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics.
    Keith SJ; Kane JM; Turner M; Conley RR; Nasrallah HA
    J Clin Psychiatry; 2004 Jan; 65(1):120-31. PubMed ID: 14744181
    [No Abstract]   [Full Text] [Related]  

  • 9. Catatonia and mild neuroleptic malignant syndrome after initiation of long-acting injectable risperidone: case report.
    Mall GD; Hake L; Benjamin AB; Adityanjee A
    J Clin Psychopharmacol; 2008 Oct; 28(5):572-3. PubMed ID: 18794658
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of long-acting risperidone.
    Pinninti NR; Mago R
    Psychiatr Serv; 2005 Jan; 56(1):105; author reply 106-7. PubMed ID: 15637204
    [No Abstract]   [Full Text] [Related]  

  • 11. Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia.
    Keith SJ; Pani L; Nick B; Emsley R; San L; Turner M; Conley R; Scully P; Chue PS; Lachaux B
    Psychiatr Serv; 2004 Sep; 55(9):997-1005. PubMed ID: 15345759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukopenia during therapy with risperidone long-acting injectable: two case reports.
    Uzun S; Kozumplik O; Jakovljević M; Folnegović-Smalc V
    J Clin Psychopharmacol; 2008 Dec; 28(6):713-4. PubMed ID: 19011449
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-acting risperidone and oral antipsychotics in unstable schizophrenia.
    Rosenheck RA; Krystal JH; Lew R; Barnett PG; Fiore L; Valley D; Thwin SS; Vertrees JE; Liang MH;
    N Engl J Med; 2011 Mar; 364(9):842-51. PubMed ID: 21366475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
    Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
    J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.
    Keith S
    Expert Rev Neurother; 2009 Jan; 9(1):9-31. PubMed ID: 19102665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone long-acting therapy in stable patients with recently diagnosed schizophrenia.
    Macfadden W; Bossie CA; Turkoz I; Haskins JT
    Int Clin Psychopharmacol; 2010 Mar; 25(2):75-82. PubMed ID: 20101185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
    Li H; Rui Q; Ning X; Xu H; Gu N
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting injectable risperidone.
    Ehret MJ; Fuller MA
    Ann Pharmacother; 2004 Dec; 38(12):2122-7. PubMed ID: 15522979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.